Research Analysts Issue Forecasts for LRMR Q2 Earnings
Larimar Therapeutics, Inc. (NASDAQ:LRMR – Free Report) – Investment analysts at Lifesci Capital issued their Q2 2025 EPS estimates for shares of Larimar Therapeutics in a research report issued on Monday, June 23rd. Lifesci Capital analyst C. Jubinville anticipates that the company will earn ($0.46) per share for the quarter. The consensus estimate for Larimar […]
Larimar Therapeutics, Inc. (NASDAQ:LRMR – Free Report) – Investment analysts at Lifesci Capital issued their Q2 2025 EPS estimates for shares of Larimar Therapeutics in a research report issued on Monday, June 23rd. Lifesci Capital analyst C. Jubinville anticipates that the company will earn ($0.46) per share for the quarter. The consensus estimate for Larimar […]
